We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
FCDO travel advice for Cayman Islands. Includes safety and security, insurance, entry requirements and legal differences.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Statement of the Calorie Reduction Expert Group.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
A technical report outlining guidelines for industry, 2017 baseline calorie levels and next steps.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Information on Reductions to The Frequency Of Returns To The Pensions Regulator By Defined Contribution Schemes With 2-4 Members
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Information about controlled drugs licences for companies that possess, manufacture, produce or supply controlled drugs in England, Wales or Scotland.
Paper prepared by Imperial College on the impact of non-pharmaceutical interventions.
Case study on the 2004 Food Standards Agency (FSA) salt reduction programme.
Public consultation on a set of proposals to make Aquiette 2.5mg Tablets (oxybutynin hydrochloride) available from pharmacies
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).